40.21 M EUR
262.65 M EUR
2.41 M
About CLINICA BAVIERA S.A.
Sector
Industry
CEO
Eduardo Baviera Sabater
Website
Headquarters
Madrid
Founded
1992
ISIN
ES0119037010
FIGI
BBG000PGB5Q4
Clínica Baviera SA is engaged in the provision of diagnosis and treatment for eye disorders. It specializes in the treatment of glaucoma, cataract, vitreous and retinal detachment, and strabismus or squinting. The company was founded by Eduardo Baviera Sabater, Julio Baviera Sabater, Luis Miguel Raga, and Fernando Llovet Osuna on February 5, 1992 and is headquartered in Madrid, Spain.
Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Displays a symbol's price movements over previous years to identify recurring trends.
Related stocks
Frequently Asked Questions
The current price of CBAV is 35.2 EUR — it has increased by 2.06% in the past 24 hours. Watch CLINICA BAVIERA S.A. stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on BME exchange CLINICA BAVIERA S.A. stocks are traded under the ticker CBAV.
CBAV stock has risen by 3.27% compared to the previous week, the month change is a −2.80% fall, over the last year CLINICA BAVIERA S.A. has showed a 23.94% increase.
We've gathered analysts' opinions on CLINICA BAVIERA S.A. future price: according to them, CBAV price has a max estimate of 39.00 EUR and a min estimate of 39.00 EUR. Watch CBAV chart and read a more detailed CLINICA BAVIERA S.A. stock forecast: see what analysts think of CLINICA BAVIERA S.A. and suggest that you do with its stocks.
CBAV reached its all-time high on Oct 21, 2024 with the price of 39.5 EUR, and its all-time low was 3.6 EUR and was reached on Dec 14, 2012. View more price dynamics on CBAV chart.
See other stocks reaching their highest and lowest prices.
See other stocks reaching their highest and lowest prices.
CBAV stock is 4.57% volatile and has beta coefficient of 0.56. Track CLINICA BAVIERA S.A. stock price on the chart and check out the list of the most volatile stocks — is CLINICA BAVIERA S.A. there?
Today CLINICA BAVIERA S.A. has the market capitalization of 554.97 M, it has decreased by −0.58% over the last week.
Yes, you can track CLINICA BAVIERA S.A. financials in yearly and quarterly reports right on TradingView.
CBAV net income for the last quarter is 13.11 M EUR, while the quarter before that showed 4.05 M EUR of net income which accounts for 223.50% change. Track more CLINICA BAVIERA S.A. financial stats to get the full picture.
CLINICA BAVIERA S.A. dividend yield was 4.08% in 2024, and payout ratio reached 50.61%. The year before the numbers were 5.53% and 57.64% correspondingly. See high-dividend stocks and find more opportunities for your portfolio.
As of Apr 28, 2025, the company has 1.76 K employees. See our rating of the largest employees — is CLINICA BAVIERA S.A. on this list?
Like other stocks, CBAV shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade CLINICA BAVIERA S.A. stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So CLINICA BAVIERA S.A. technincal analysis shows the buy rating today, and its 1 week rating is buy. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating CLINICA BAVIERA S.A. stock shows the strong buy signal. See more of CLINICA BAVIERA S.A. technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.